EHR

OCHIN and OSIS announce partnership to support nation’s community health centers with innovative health IT solutions

The new agreement brings greater EHR platform choice to providers, while ensuring reliable access to equitable, high-quality care for roughly…

5 months ago

MEDHOST Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Access to Clinical Data and Participate in TEFCA

FRANKLIN, TN / ACCESSWIRE / July 24, 2024 / MEDHOST, a leading EHR and healthcare IT solutions provider, has announced…

5 months ago

Odyssey House Implements Oracle Health to Help Enhance Patient Care, Improve Revenue Management

Utah-based mental health organization integrates EHR and behavioral health solutions to help deliver a better care experience for patients and…

5 months ago

Holmusk and Veradigm Reach New Data Enrichment Milestone in Strategic Collaboration

Veradigm Network EHR data enables a deeper understanding of the patient journey and disorder progression NEW YORK and CHICAGO, July…

5 months ago

MangoRx Initiates Efficacy Studies on its Patented Respiratory Illness Prevention Technology

Dallas, Texas, July 24, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a leader in men’s…

5 months ago

Notable Labs Receives FDA Clearance to Proceed Further with Volasertib Phase 2 Study

Phase 2 dosing plan, agreed with FDA, paves the way to initiate patient enrollmentFOSTER CITY, Calif., July 24, 2024 (GLOBE…

5 months ago

OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis

OSE Immunotherapeutics Announces Positive Efficacy Results for Lusvertikimab in the Phase 2 trial for the treatment of Ulcerative Colitis Lusvertikimab…

5 months ago

FDA Accepts Telix NDA for New Prostate Cancer Imaging Agent

MELBOURNE, Australia, July 24, 2024 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the…

5 months ago

FDA Accepts Mesoblast’s Biologics License Application (BLA) for Ryoncil® in Children With Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)

If Approved, RYONCIL will be the First Allogeneic “Off-the-Shelf” Cellular Medicine in the US, and the First Cell Therapy for…

5 months ago

Rakovina Therapeutics Provides Update on Previously Announced Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) -- Rakovina…

5 months ago